PBAC consumer comments open for denosumab

Myeloma Australia is committed to keeping the Australian myeloma community informed about any new treatment submissions to be considered by the Pharmaceutical Benefits Advisory Committee (PBAC). The P...

Social media & sharing icons powered by UltimatelySocial